Scientific Advisory Board

The SAB, made up of recognized experts Dr. Ed Schnipper, Dr. Mark Rodger Stein and Dr. Angela Genge, strengthens ARG’s leadership and expertise in key therapeutic areas: oncology, immunology, rare and neurodegenerative diseases.

Dr. Ed Schnipper


“I am excited to work with ARG because of our mutual commitment to pursue scientific advancements leading toward new, approved medicines for patients.”

Dr. Ed Schnipper is a widely recognized expert in innovative design and management of clinical trials, in several indications particularly in oncology. He has established a reputation for being able to determine quickly and cost-effectively as to whether a drug is safe and effective.

Ed, currently the Head of Clinical Development at X-37, has played key roles in drug development from IND to NDA in diverse organizations. Previously holding leadership positions at Hoffmann-LaRoche, Alza, Cellgate, and Novacea, Ed has been instrumental in securing approvals of drugs such as Roferon A, Vesanoid, Saquinavir, Doxil, Duros Leuprolide, and Concerta.

Ed practiced medical oncology in both the academic and private practice settings before beginning his pharmaceutical career with Hoffmann-La Roche. He holds an MD from Georgetown University, and has completed fellowships in hematology at New York University and oncology at Memorial Sloan Kettering Cancer Center.

Dr. Mark Rodger Stein


“Immunology research is highly specialized, requiring multidisciplinary relationships and wide-ranging experience. ARG has the talent and expertise to execute the complex clinical trials needed in this field.”

Dr. Mark Rodger Stein is a prominent immunologist and allergist whose career has been marked by noteworthy leadership positions, continued commitment to treating patients afflicted with wide-ranging conditions, and groundbreaking achievements in research. He is particularly known for his work in primary immunodeficiency diseases.

Mark has served as Clinical Consultant in Allergy and Immunology at the National Institute of Health, Assistant Chief of Allergy and Immunology at Walter Reed Army Medical Center, and Assistant Professor of Medicine and Pediatrics at the Uniform Services Health Sciences School of Medicine in Bethesda Maryland.

Mark founded and served as Medical Director at Allergy Associates of Palm Gardens, P.A. in Florida, a practice dedicated to allergy, asthma and immunologic disorders.

Mark has distinguished himself as a researcher, first in the relationship between gastroesophageal reflux and asthma, then later in immunodeficiency and immunoglobulin therapy.

Mark earned an MD from Jefferson Medical College, completed an internship at Abington Memorial Hospital in Pennsylvania, then served 10 years in the United States Army, reaching the rank of Lieutenant Colonel. He completed an internal medicine residency at Letterman Army Medical Center in San Francisco, followed by a fellowship in allergy and immunology at National Jewish Medical and Research Center and Fitzsimons Army Medical Center in Denver, Colorado.

Dr. Angela Genge

Rare and Neurodegenerative Diseases

“ARG’s specializations in both rare and neurodegenerative disease clinical trials create a valuable knowledge base and a collaborative environment in which we can innovate effectively together.”

Dr. Angela Genge has been the Director of the Clinical Research Unit at the Montreal Neurological Institute since 2004. Her career is notable for her groundbreaking research, prominent leadership positions, and significant distinctions.

Angela’s areas of research include rare neurological diseases, and she is known for clinical expertise as well as the introduction of innovative therapies. She has specifically led studies in the following neuromuscular disorders: ALS, myopathies, neuropathies, myasthenia gravis and pain.

Angela completed her medical degree at the Memorial University of Newfoundland. She completed her Canadian and American certifications in Internal Medicine and Neurology prior to completing a fellowship in neuromuscular diseases. She joined the staff of the Montreal Neurological Hospital in 1994 and became Director of the ALS Clinic in 1998.

Angela has distinguished herself in her career, receiving the Forbes Norris Award, the DIVA of Distinction Award, and the Governor General Diamond Jubilee Award.